Ventyx Biosciences, Inc. (VTYX) Misses Q4 EPS by 3c

Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q4 EPS of ($0.62), $0.03 worse than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• RBC Capital Reiterates Sector Perform Rating on ExxonMobil (XOM)
• HP shares slide as tech giant forecasts 2027 PC market slump